MDxHealth SA

Research MDxHealth SA (MDXH) on Bullrun: market cap USD 20.55M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMDXH
• ExchangeNASDAQ
• CountryBelgium
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 20.55M
• Financial periodQ1 2026
• RevenueUSD 27.39M
• Net income-USD 8.87M
• Free cash flow-USD 1.85M
• Gross margin60.7%

Valuation Snapshot

latest market cap is USD 20.55M.

About MDxHealth SA

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer;

Frequently asked questions

What is MDxHealth SA's market cap?

MDxHealth SA's market capitalization is USD 20.55M.

What does MDxHealth SA do?

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.